MetaCap

Astrana Health (ASTH) vs ICF International (ICFI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Astrana Health (ASTH) has outperformed ICF International (ICFI) over the past year, gaining 28.4% versus a loss of 0.6%. Over five years, ICFI leads with a -22.7% price change compared with -69.4% for ASTH. Astrana Health is the larger company by market cap ($1.44 billion vs $1.39 billion), about 1.0 times the size.

On valuation, Astrana Health trades at a lower forward P/E (8.3x vs 10.1x for ICF International). ICF International pays a dividend yielding 0.72%, while Astrana Health does not currently pay one. ICF International converts more of its revenue into profit, with a net margin of 4.9% versus 0.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASTH+28.44%ICFI-0.59%
+129%+49%-30%
Nov 21, 20251 yearNov 20, 2026
ASTH-74.53%ICFI-26.27%
+72%-9%-91%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASTH versus ICFI key metrics
MetricASTHICFI
Share price$28.90$77.56
Market cap$1.44B$1.39B
1-day change+0.77%+1.45%
YTD return+16.49%-9.07%
1-year return+28.44%-0.59%
5-year return-69.44%-22.66%
P/E ratio (TTM)26.7614.63
Forward P/E8.3010.12
EPS (TTM)$1.08$5.30
Dividend yield0.00%0.72%
Annual dividend$0.00$0.56
Revenue (latest FY)$3.18B$1.87B
Revenue growth (YoY)+56.39%-7.27%
Net income (latest FY)$22.49M$91.59M
Gross margin10.73%37.16%
Operating margin2.47%7.77%
Net margin0.71%4.89%
52-week high$51.60$100.63
52-week low$18.08$58.83
Distance from 52-week high-43.99%-22.93%
Analyst consensusstrong_buybuy
Avg. price target upside+79.55%+41.50%
Average volume377.18K183.90K
Shares outstanding49.67M17.94M
Employees3,0006,972
SectorConsumer DiscretionaryConsumer Discretionary
IndustryProfessional ServicesProfessional Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ASTH has outperformed ICFI by 29.0 percentage points over the past year.
  • Astrana Health trades at a higher earnings multiple (26.8x vs 14.6x trailing P/E).
  • Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs -7.27%).

About Astrana Health

ASTH stock →

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.

Consumer Discretionary · Professional Services · 3,000 employees

About ICF International

ICFI stock →

ICF International, Inc. provides management, technology, and policy consulting and implementation services to government and commercial clients in the United States and internationally.

Consumer Discretionary · Professional Services · 6,972 employees

ASTH vs ICFI FAQ

Which is bigger, Astrana Health or ICF International?

Astrana Health (ASTH) is larger, with a market capitalization of $1.44B compared with $1.39B for ICF International (ICFI).

Which stock has performed better over the past year, ASTH or ICFI?

ASTH returned +28.44% over the past 12 months, compared with -0.59% for ICFI (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ASTH or ICFI?

ICFI has the lower trailing P/E at 14.6, versus 26.8 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Astrana Health or ICF International?

ICF International pays a dividend yielding 0.72%, while Astrana Health does not currently pay a regular dividend.

Are Astrana Health and ICF International in the same industry?

Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.

More comparisons